PBYI insider transactions
Puma Biotechnology Inc (PBYI) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for PBYI
- President and CEO Auerbach Alan H sold $364,051 worth of shares (44,058 units at $8.26) as part of a pre-agreed trading plan, decreasing direct ownership by 0.60% to 7,261,671 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Officer Hunt Douglas M sold $69,905 worth of shares (8,460 units at $8.26) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 196,841 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Chief Financial Officer Nougues Maximo F sold $77,557 worth of shares (9,386 units at $8.26) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 230,637 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Director Wilson Troy Edward was granted 27,000 shares and sold $77,748 worth of shares (10,800 units at $7.20) as part of a pre-agreed trading plan, increasing direct ownership by 37% to 59,750 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Director Stuglik Brian M was granted 27,000 shares and sold $58,311 worth of shares (8,100 units at $7.20) as part of a pre-agreed trading plan, increasing direct ownership by 20% to 113,858 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Director Senderowicz Adrian sold $194,311 worth of shares (27,000 units at $7.20) as part of a pre-agreed trading plan and was granted 27,000 shares (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Director Miller Michael Patrick was granted 27,000 shares, increasing direct ownership by 50% to 81,000 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Director Moyes Jay M was granted 27,000 shares and sold $158,796 worth of shares (22,000 units at $7.22) as part of a pre-agreed trading plan, increasing direct ownership by 9% to 58,322 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Director Dorval Allison was granted 27,000 shares and sold $83,579 worth of shares (11,610 units at $7.20) as part of a pre-agreed trading plan, increasing direct ownership by 20% to 90,780 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Director Cesano Alessandra was granted 27,000 shares, increasing direct ownership by 65% to 68,850 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- President and CEO Auerbach Alan H was granted 159,778 shares, increasing direct ownership by 2% to 7,305,729 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Officer Hunt Douglas M was granted 49,394 shares, increasing direct ownership by 32% to 205,301 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Chief Financial Officer Nougues Maximo F was granted 46,739 shares, increasing direct ownership by 24% to 240,023 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- President and CEO Auerbach Alan H sold $204,878 worth of shares (34,950 units at $5.86), decreasing direct ownership by 0.49% to 7,145,951 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Officer Hunt Douglas M sold $52,696 worth of shares (8,987 units at $5.86), decreasing direct ownership by 5% to 155,907 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Chief Financial Officer Nougues Maximo F sold $64,187 worth of shares (10,945 units at $5.86), decreasing direct ownership by 5% to 193,284 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Director Miller Michael Patrick sold $97,228 worth of shares (20,000 units at $4.86), decreasing direct ownership by 27% to 54,000 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Director Cesano Alessandra sold $90,909 worth of shares (27,000 units at $3.37), decreasing direct ownership by 39% to 41,850 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Chief Financial Officer Nougues Maximo F sold $33,649 worth of shares (9,522 units at $3.53), decreasing direct ownership by 4% to 204,229 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Officer Hunt Douglas M sold $27,624 worth of shares (7,817 units at $3.53), decreasing direct ownership by 5% to 164,894 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- President and CEO Auerbach Alan H sold $166,702 worth of shares (47,172 units at $3.53), decreasing direct ownership by 0.65% to 7,180,901 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Director Wilson Troy Edward sold $36,720 worth of shares (10,800 units at $3.40), decreasing direct ownership by 20% to 43,550 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Director Stuglik Brian M sold $27,459 worth of shares (8,100 units at $3.39), decreasing direct ownership by 8% to 94,958 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Director Senderowicz Adrian sold $91,800 worth of shares (27,000 units at $3.40), decreasing direct ownership by 50% to 27,000 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Director Moyes Jay M sold $74,800 worth of shares (22,000 units at $3.40), decreasing direct ownership by 29% to 53,322 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Director Dorval Allison sold $39,474 worth of shares (11,610 units at $3.40), decreasing direct ownership by 13% to 75,390 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Director Cesano Alessandra sold $41,310 worth of shares (12,150 units at $3.40), decreasing direct ownership by 15% to 68,850 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Director Miller Michael Patrick was granted 27,000 shares, increasing direct ownership by 57% to 74,000 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Director Senderowicz Adrian was granted 27,000 shares, increasing direct ownership by 100% to 54,000 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Director Moyes Jay M was granted 27,000 shares, increasing direct ownership by 56% to 75,322 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Director Dorval Allison was granted 27,000 shares, increasing direct ownership by 45% to 87,000 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Director Stuglik Brian M was granted 27,000 shares, increasing direct ownership by 35% to 103,058 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Director Wilson Troy Edward was granted 27,000 shares, increasing direct ownership by 99% to 54,350 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Director Cesano Alessandra was granted 27,000 shares, increasing direct ownership by 50% to 81,000 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Chief Financial Officer Nougues Maximo F was granted 61,456 shares, increasing direct ownership by 40% to 213,751 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Chief Commercial Officer Ludwig Jeffrey Jerome was granted 47,841 shares, increasing direct ownership by 44% to 156,792 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Officer Hunt Douglas M was granted 48,117 shares, increasing direct ownership by 39% to 172,711 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- President and CEO Auerbach Alan H was granted 198,399 shares, increasing direct ownership by 3% to 7,228,073 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Chief Financial Officer Nougues Maximo F sold $32,232 worth of shares (10,227 units at $3.15), decreasing direct ownership by 6% to 152,295 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Chief Commercial Officer Ludwig Jeffrey Jerome sold $29,743 worth of shares (9,437 units at $3.15), decreasing direct ownership by 8% to 108,951 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Officer Hunt Douglas M sold $27,209 worth of shares (8,633 units at $3.15), decreasing direct ownership by 6% to 124,594 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- President and CEO Auerbach Alan H sold $106,657 worth of shares (33,841 units at $3.15), decreasing direct ownership by 0.48% to 7,029,674 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Director Miller Michael Patrick sold $81,466 worth of shares (23,358 units at $3.49), decreasing direct ownership by 33% to 47,000 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Chief Financial Officer Nougues Maximo F sold $15,382 worth of shares (4,156 units at $3.70), decreasing direct ownership by 2% to 162,522 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Chief Commercial Officer Ludwig Jeffrey Jerome sold $9,615 worth of shares (2,598 units at $3.70), decreasing direct ownership by 2% to 118,388 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Officer Hunt Douglas M sold $13,461 worth of shares (3,637 units at $3.70), decreasing direct ownership by 3% to 133,227 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- President and CEO Auerbach Alan H sold $81,128 worth of shares (21,920 units at $3.70), decreasing direct ownership by 0.31% to 7,063,515 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Chief Financial Officer Nougues Maximo F sold $17,307 worth of shares (5,295 units at $3.27), decreasing direct ownership by 3% to 166,678 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Chief Commercial Officer Ludwig Jeffrey Jerome sold $19,778 worth of shares (6,051 units at $3.27), decreasing direct ownership by 5% to 120,986 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Officer Hunt Douglas M sold $14,215 worth of shares (4,349 units at $3.27), decreasing direct ownership by 3% to 136,864 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- President and CEO Auerbach Alan H sold $61,726 worth of shares (18,885 units at $3.27), decreasing direct ownership by 0.27% to 7,085,435 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Director Wilson Troy Edward was granted 27,000 shares, increasing direct ownership by 7,714% to 27,350 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Director Stuglik Brian M was granted 27,000 shares, increasing direct ownership by 55% to 76,058 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Director Senderowicz Adrian was granted 27,000 shares (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Director Miller Michael Patrick was granted 27,000 shares, increasing direct ownership by 39% to 95,358 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Director Moyes Jay M was granted 27,000 shares, increasing direct ownership by 127% to 48,322 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Director Dorval Allison was granted 27,000 shares, increasing direct ownership by 82% to 60,000 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Director Cesano Alessandra was granted 27,000 shares, increasing direct ownership by 100% to 54,000 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Director Wilson Troy Edward sold $89,902 worth of shares (27,000 units at $3.33), decreasing direct ownership by 99% to 350 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)
- Director Stuglik Brian M sold $33,528 worth of shares (9,900 units at $3.39), decreasing direct ownership by 17% to 49,058 units (SEC Form 4)4 - PUMA BIOTECHNOLOGY, INC. (0001401667) (Issuer)